Celgene Corp (CELG)

Drugs are bad. Just say no to drugs. Unless they're legal, and they're going to help you overcome pain or some other disease. Celgene is a biopharmaceutical company that makes innovative drugs - that are legal - to treat cancer and immune-inflammatory diseases.

Show Chart

Events

  • May242012
    Celgene Corporation Presents at Biomarkers World Europe, May-24-2012 04:00 PM
  • May302012
    Celgene Corporation Presents at Sanford C. Bernstein & Co.'s 28th Annual Strategic Decisions Conference, May-30-2012 03:00 PM
  • June132012
    Celgene Corporation, Annual General Meeting, Jun 13, 2012
  • July262012
    Celgene Corporation expected to report Q2 2012 results on July 26, 2012. This event was calculated by Capital IQ (Created on April 27, 2012).
  • January242013
    Celgene Corporation expected to report Fiscal Year 2012 results on January 24, 2013. This event was calculated by Capital IQ (Created on April 19, 2012).

Members who own this company also own

Current price per share


Today's gain: $0.23 (0.33%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon